170 related articles for article (PubMed ID: 22372904)
21. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
[TBL] [Abstract][Full Text] [Related]
22. [Identification and characterization of microRNA involving in malignant pleural mesothelioma].
Bonotti A; Foddis R; Papa A; Bigotti M; de Santi C; Gemignani F; Landi S; Cristaudo A
G Ital Med Lav Ergon; 2012; 34(3 Suppl):552-4. PubMed ID: 23405713
[TBL] [Abstract][Full Text] [Related]
23. MT1-MMP plays an important role in an invasive activity of malignant pleural mesothelioma cell.
Doi T; Maniwa Y; Tanaka Y; Tane S; Hashimoto S; Ohno Y; Nishio W; Nishimura Y; Ohbayashi C; Okita Y; Hayashi Y; Yoshimura M
Exp Mol Pathol; 2011 Feb; 90(1):91-6. PubMed ID: 20969861
[TBL] [Abstract][Full Text] [Related]
24. [Malignant pleural mesothelioma: early diagnosis and multimodality management].
Pavia R; Mondello B; Barone M; Surleti S; Puliafito M; Barresi P
G Chir; 2005; 26(6-7):257-60. PubMed ID: 16332304
[TBL] [Abstract][Full Text] [Related]
25. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
Greillier L; Marco S; Barlesi F
Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
[TBL] [Abstract][Full Text] [Related]
27. Malignant pleural mesothelioma: overview of the North American and European experience.
Kukreja J; Jaklitsch MT; Wiener DC; Sugarbaker DJ; Burgers S; Baas P
Thorac Surg Clin; 2004 Nov; 14(4):435-45. PubMed ID: 15559050
[TBL] [Abstract][Full Text] [Related]
28. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.
Kristensen LS; Nielsen HM; Hager H; Hansen LL
Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of Bax and Fas ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma.
Kokturk N; Firat P; Akay H; Kadilar C; Ozturk C; Zorlu F; Gungen Y; Emri S
Lung Cancer; 2005 Nov; 50(2):189-98. PubMed ID: 16043260
[TBL] [Abstract][Full Text] [Related]
30. [Environmental cancer: malignant pleural mesothelioma].
Margery J; Ruffié P
Bull Cancer; 2008 Jan; 95(1):77-86. PubMed ID: 18230573
[TBL] [Abstract][Full Text] [Related]
31. Malignant pleural mesothelioma: from the bench to the bedside.
Astoul P; Roca E; Galateau-Salle F; Scherpereel A
Respiration; 2012; 83(6):481-93. PubMed ID: 22710421
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
Rena O; Boldorini LR; Gaudino E; Casadio C
J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and staging of malignant pleural mesothelioma].
Sohrab S; Konietzko N
Pneumologie; 2002 Jun; 56(6):382-7. PubMed ID: 12063622
[TBL] [Abstract][Full Text] [Related]
34. Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells.
Kawaguchi K; Murakami H; Taniguchi T; Fujii M; Kawata S; Fukui T; Kondo Y; Osada H; Usami N; Yokoi K; Ueda Y; Yatabe Y; Ito M; Horio Y; Hida T; Sekido Y
Carcinogenesis; 2009 Jul; 30(7):1097-105. PubMed ID: 19380521
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.
Maki Y; Asano H; Toyooka S; Soh J; Kubo T; Katsui K; Ueno T; Shien K; Muraoka T; Tanaka N; Yamamoto H; Tsukuda K; Kishimoto T; Kanazawa S; Miyoshi S
Anticancer Res; 2012 Nov; 32(11):4871-5. PubMed ID: 23155254
[TBL] [Abstract][Full Text] [Related]
36. Future developments in the management of malignant pleural mesothelioma.
Zucali PA; De Vincenzo F; Simonelli M; Santoro A
Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
[TBL] [Abstract][Full Text] [Related]
37. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma.
Pass HI
Chest Surg Clin N Am; 1994 Aug; 4(3):497-515. PubMed ID: 7953481
[TBL] [Abstract][Full Text] [Related]
38. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
Grigoriu BD; Scherpereel A; Devos P; Chahine B; Letourneux M; Lebailly P; Grégoire M; Porte H; Copin MC; Lassalle P
Clin Cancer Res; 2007 May; 13(10):2928-35. PubMed ID: 17504993
[TBL] [Abstract][Full Text] [Related]
39. [Malignant mesothelioma].
Scherpereel A
Rev Prat; 2009 Jun; 59(6):751-5. PubMed ID: 19642427
[TBL] [Abstract][Full Text] [Related]
40. [Immunotherapy and malignant mesothelioma: clinical perspectives].
Grégoire M; Ebstein F
Bull Cancer; 2007 Jan; 94(1):23-31. PubMed ID: 17237002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
